---
title: "Pharmcist-based gout mgmt program in large health plan pilot | Sutter Health"
description: "Pharmacist-staffed program can effectively and safely lower and maintain uric acid levels in a high percentage of patients with recurrent gout in primary care."
url: "https://www.sutterhealth.org/research/publications/pharmcist-based-gout-mgmt-program-in-large-health-plan-pilot-1055312740"
---

1.  [Home](https://www.sutterhealth.org/) /
2.  [Research](https://www.sutterhealth.org/research) /
3.  [Research publications](https://www.sutterhealth.org/research/publications) /
4.  Pharmcist-based gout mgmt program in large health plan pilot

# Effectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot study.

Goldfien RD, Ng MS, Yip G, Hwe A, Jacobson A, Pressman A, & Avins AL.

_BMJ Open. 4(1):e003627. doi: 10.1136/bmjopen-2013-003627._

2014-01-10

## Abstract

OBJECTIVES: The study objective was to determine the feasibility of using a pharmacist-staffed, protocol-based structured approach to improving the management of chronic, recurrent gout.

SETTING: The study was carried out in the outpatient clinic of a single Kaiser Permanente medical centre. This is a community-based clinic.

PARTICIPANTS: We report on 100 consecutive patients between the ages of 21 and 94 (75% men) with chronic or recurrent gout, referred by their primary physicians for the purpose of management of urate-lowering therapy. Patients with stage 5 chronic kidney disease or end-stage kidney disease were excluded.

INTERVENTIONS: The programme consisted of a trained clinical pharmacist and a rheumatologist. The pharmacist contacted each patient by phone, provided educational and dietary materials, and used a protocol that employs standard gout medications to achieve and maintain a serum uric acid (sUA) level of 6 mg/dL or less. Incident gout flares or adverse reactions to medications were managed in consultation with the rheumatologist.

PRIMARY OUTCOME MEASURE: The primary outcome measure was the achievement and maintenance of an sUA of 6 or less for a period of at least 3 months.RESULTS: In 95 evaluable patients enrolled in our pilot programme, an sUA of 6 mg/dL or less was achieved and maintained in 78 patients with 4 still in the programme to date. Five patients declined to participate after referral, and another 13 patients did not complete the programme. (The majority of these were due to non-adherence.)

CONCLUSIONS: A structured pharmacist-staffed programme can effectively and safely lower and maintain uric acid levels in a high percentage of patients with recurrent gout in a primary care setting. This care model is simple to implement, efficient and warrants further validation in a clinical trial.

[PubMed abstract](https://www.ncbi.nlm.nih.gov/pubmed/?term=24413343)

## Research topics

-   [Arthritis](https://www.sutterhealth.org/research-search-results?query=%22%5C%22Arthritis%5C%22%22)
-   [Disease Management](https://www.sutterhealth.org/research-search-results?query=%22%5C%22Disease+Management%5C%22%22)
-   [Kidney Disease](https://www.sutterhealth.org/research-search-results?query=%22%5C%22Kidney+Disease%5C%22%22)

## Related publications

[View all publications](https://www.sutterhealth.org/research-search-results?verticalKey=research_publication)

-   Publication
    
    ### [Electromagnetic navigational bronchoscopy spares a drunken crab from the surgeon's knife.](https://www.sutterhealth.org/research/publications/enb-saves-drunken-crab-fr-surgery-1055312421)
    
    Parikh MS, Seeley E, Krishna G.
    
    J Bronchology Interv Pulmonol. \[Epub ahead of print\]
    
    2016 Apr 11
    
-   Publication
    
    ### [Cardiovascular magnetic resonance phase contrast imaging.](https://www.sutterhealth.org/research/publications/cardiovasc-mri-phase-contrast-1055312458)
    
    Nayak KS, Nielsen JF, Bernstein MA, Markl M, D Gatehouse P, M Botnar R, Saloner D, Lorenz C, Wen H, S Hu B, Epstein FH, N Oshinski J, Raman SV.
    
    J Cardiovasc Magn Reson. 17(1):71. doi: 10.1186/s12968-015-0172-7.
    
    2015 Aug 09
    
-   Publication
    
    ### [Subtalar joint arthrodesis using a single lag screw.](https://www.sutterhealth.org/research/publications/subtalar-joint-arthrodesis-use-one-lag-screw-1055312972)
    
    Haskell A, Pfeiff C, Mann R.
    
    Foot Ankle Int. 25(11):774-7.
    
    2004 Nov 01
    
-   Publication
    
    ### [Authoritarian physicians and patients' fear of being labeled 'difficult' among key obstacles to shared decision making.](https://www.sutterhealth.org/research/publications/pts-fear-label-difficult-obstacle-shared-decmaking-1055312526)
    
    Frosch DL, May SG, Rendle KA, Tietbohl C, Elwyn G.
    
    Health Aff (Millwood). 31(5):1030-8. doi: 10.1377/hlthaff.2011.0576.
    
    2012 May 01
    
-   Publication
    
    ### [Magnetic resonance imaging and incidental findings of lateral ankle pathologic features with asymptomatic ankles.](https://www.sutterhealth.org/research/publications/mri-lateral-ankle-pathology-no-symptoms-1055312431)
    
    Saxena A, Luhadiya A, Ewen B, Goumas C.
    
    J Foot Ankle Surg. 50(4):413-5. doi: 10.1053/j.jfas.2011.03.011. Epub 2011 May 12.
    
    2011 Jul 01
    

[View all publications](https://www.sutterhealth.org/research-search-results?verticalKey=research_publication)

```json
{"@context":"https://schema.org","@type":"MedicalOrganization","name":"Sutter Health","@id":"https://www.sutterhealth.org/#medicalorganization","url":"https://www.sutterhealth.org","logo":"https://www.sutterhealth.org/static/images/sutter-health-logo.svg","address":{"@type":"PostalAddress","streetAddress":"2200 River Plaza Drive","addressLocality":"Sacramento","addressRegion":"CA","postalCode":"95833","addressCountry":"US"},"areaServed":{"@type":"AdministrativeArea","name":"California"},"sameAs":["https://www.facebook.com/SutterHealth","https://www.instagram.com/sutterhealth/","https://x.com/SutterHealth","https://www.youtube.com/sutterhealth","https://www.linkedin.com/company/sutter-health","https://en.wikipedia.org/wiki/Sutter_Health"]}
```

```json
{"@context":"https://schema.org","@type":"BreadcrumbList","@id":"https://www.sutterhealth.org/research/publications/pharmcist-based-gout-mgmt-program-in-large-health-plan-pilot-1055312740#breadcrumblist","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://www.sutterhealth.org/"},{"@type":"ListItem","position":2,"name":"Research","item":"https://www.sutterhealth.org/research"},{"@type":"ListItem","position":3,"name":"Research publications","item":"https://www.sutterhealth.org/research/publications"},{"@type":"ListItem","position":4,"name":"Pharmcist-based gout mgmt program in large health plan pilot"}]}
```

```json
{"@context":"https://schema.org","@type":"MedicalScholarlyArticle","@id":"https://www.sutterhealth.org/research/publications/pharmcist-based-gout-mgmt-program-in-large-health-plan-pilot-1055312740#medicalscholarlyarticle","name":"Effectiveness of a pharmacist-based gout care management programme in a large integrated health plan: results from a pilot study.","headline":"Pharmcist-based gout mgmt program in large health plan pilot","abstract":"OBJECTIVES: The study objective was to determine the feasibility of using a pharmacist-staffed, protocol-based structured approach to improving the management of chronic, recurrent gout. SETTING: The study was carried out in the outpatient clinic of a single Kaiser Permanente medical centre. This is a community-based clinic. PARTICIPANTS: We report on 100 consecutive patients between the ages of 21 and 94 (75% men) with chronic or recurrent gout, referred by their primary physicians for the purpose of management of urate-lowering therapy. Patients with stage 5 chronic kidney disease or end-stage kidney disease were excluded. INTERVENTIONS: The programme consisted of a trained clinical pharmacist and a rheumatologist. The pharmacist contacted each patient by phone, provided educational and dietary materials, and used a protocol that employs standard gout medications to achieve and maintain a serum uric acid (sUA) level of 6 mg/dL or less. Incident gout flares or adverse reactions to medications were managed in consultation with the rheumatologist. PRIMARY OUTCOME MEASURE: The primary outcome measure was the achievement and maintenance of an sUA of 6 or less for a period of at least 3 months.RESULTS: In 95 evaluable patients enrolled in our pilot programme, an sUA of 6 mg/dL or less was achieved and maintained in 78 patients with 4 still in the programme to date. Five patients declined to participate after referral, and another 13 patients did not complete the programme. (The majority of these were due to non-adherence.) CONCLUSIONS: A structured pharmacist-staffed programme can effectively and safely lower and maintain uric acid levels in a high percentage of patients with recurrent gout in a primary care setting. This care model is simple to implement, efficient and warrants further validation in a clinical trial.","description":"Pharmacist-staffed program can effectively and safely lower and maintain uric acid levels in a high percentage of patients with recurrent gout in primary care.","keywords":["Arthritis","Disease Management","Kidney Disease"],"datePublished":"2014-01-10","url":"https://www.sutterhealth.org/research/publications/pharmcist-based-gout-mgmt-program-in-large-health-plan-pilot-1055312740","inLanguage":"en-US","identifier":[{"@type":"PropertyValue","propertyID":"DOI","value":"10.1136/bmjopen-2013-003627"}],"sameAs":["https://doi.org/10.1136/bmjopen-2013-003627"],"isPartOf":{"@type":"Periodical","name":"BMJ Open"},"author":[{"@type":"Person","name":"Goldfien RD"},{"@type":"Person","name":"Ng MS"},{"@type":"Person","name":"Yip G"},{"@type":"Person","name":"Hwe A"},{"@type":"Person","name":"Jacobson A"},{"@type":"Person","name":"Pressman A"},{"@type":"Person","name":"Avins AL"}],"sourceOrganization":{"@type":"MedicalOrganization","name":"Palo Alto Medical Foundation Research Institute"},"about":[{"@type":"DefinedTerm","name":"Arthritis","url":"https://www.sutterhealth.org/research-search-results?facets=%5B%7B%22i%22%3A%22c_researchTopics.name%22%2C%22v%22%3A%5B%22Arthritis%22%5D%7D%5D&verticalKey=research_publication"},{"@type":"DefinedTerm","name":"Disease Management","url":"https://www.sutterhealth.org/research-search-results?facets=%5B%7B%22i%22%3A%22c_researchTopics.name%22%2C%22v%22%3A%5B%22Disease+Management%22%5D%7D%5D&verticalKey=research_publication"},{"@type":"DefinedTerm","name":"Kidney Disease","url":"https://www.sutterhealth.org/research-search-results?facets=%5B%7B%22i%22%3A%22c_researchTopics.name%22%2C%22v%22%3A%5B%22Kidney+Disease%22%5D%7D%5D&verticalKey=research_publication"}],"mainEntityOfPage":{"@type":"WebPage","@id":"https://www.sutterhealth.org/research/publications/pharmcist-based-gout-mgmt-program-in-large-health-plan-pilot-1055312740","breadcrumb":{"@id":"https://www.sutterhealth.org/research/publications/pharmcist-based-gout-mgmt-program-in-large-health-plan-pilot-1055312740#breadcrumblist"}}}
```
